1Y Close · As of Aug 26, 2026
Precision Biosensor operates in the Medical, Precision & Optical sector.
Legal name: Precision Biosensor Inc.
In fiscal year 2025, Precision Biosensor (335810) reported revenue of 19.9 billion KRW, up 4.1% from 19.1 billion KRW a year earlier.
Operating profit was -5.4 billion KRW and net income was -10.0 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 32.2 billion KRW, with a P/B of 0.98.
These figures can be verified in the DART filing (receipt no. 20260317000631).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 19.9B | -5.4B | -10.0B |
| 2024 | 19.1B | -5.4B | -7.3B |
| 2023 | 20.4B | -4.8B | -4.5B |
Recent Filings
Early CB Acquisition (Including Overseas CB)
Semi-Annual Report (2026.06)
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-18 | Early CB Acquisition (Including Overseas CB) |
| 2026-08-14 | Semi-Annual Report (2026.06) |